InsidersTradesSigma
Total declarations
Companies
▲ Purchases (0 ops.)
▼ Sales (2 ops.)
Insider track record
CEODisclosed buys
0
Disclosed sells
2
T+90 hit rate
0%
T+90 mean return
-6.7%
Across 1 buy signal with a settled T+90 return. Return basis: close on the day after publication.
Signal history
Browse the full record of transactions filed by Simonian Nancy A, Chairman & CEO. Insider active across 2 companies, notably Seagen Inc.. Cumulatively, 15 disclosures have been published. Split: 0 buy · 2 sells. Total volume traded: €44k. History available since 14 May 2021. The latest transaction was disclosed on 2 December 2024 (Cession). Regulator: SEC (Form 4). The full history is free.
Declarations15 total
37,070 shares@ US$0.27029.2% of flowCommon StockSEC:0000950170-24-133338:0
134,713 shares@ US$0.265333.1% of flowCommon StockSEC:0000950170-24-131591:0
40,125 sharesCommon StockSEC:0000950170-24-120874:0
4,000 shares0Common StockSEC:0000950170-24-070706:0
6,000 sharesCommon StockSEC:0000950170-24-040308:0
62,753 shares@ US$229.0094.6% of flowCommon StockSEC:0000950170-23-070884:0
40,125 sharesCommon StockSEC:0001209191-23-054174:0
2,044 shares0Common StockSEC:0001203311-23-000059:0
6,000 sharesCommon StockSEC:0001209191-23-022969:0
8,750 shares@ US$36.702.2% of flowCommon StockSEC:0001203311-22-000065:0
1,503 shares0Common StockSEC:0000899243-22-018458:0
58,883 shares@ US$1.12100.0% of flowCommon StockSEC:0001209191-22-022499:0
25,000 shares@ US$20.04100.0% of flowCommon StockSEC:0000899243-22-009424:0
1,402 shares0Common StockSEC:0001203311-21-000036
1,402 shares0Common StockSEC:0001203311-21-000036:0
15 of 15 declarations
About Simonian Nancy A
Nancy A. Simonian is the President and CEO of Seagen Inc. and Syros Pharmaceuticals, Inc. She leads both companies with a vision focused on innovation and research. Her leadership is essential for achieving the strategic and operational objectives of these organizations.
